| 11352405 |
GLP-1/glucagon receptor agonists in the treatment of fatty liver disease and steatohepatitis |
Aimo Kannt, Maximilian BIELOHUBY, Ralf Elvert, Michael Wagner, Martin Bossart +2 more |
2022-06-07 |
$27,001,000 |
| 11046743 |
Selective glucagon receptor agonists comprising a chelating moiety for imaging purposes |
Oliver Plettenburg, Andreas Evers, Michael Wagner, Martin Bossart, Romain BERTRAND |
2021-06-29 |
|
| 10806797 |
Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjugate |
Dieter Kadereit, Michael Wagner, Thomas Olpp, Nino Meyer, Pradeep K. Dhal +7 more |
2020-10-20 |
$20,781,000 |
| 10758592 |
Exendin-4 derivatives as dual GLP1/glucagon agonists |
Michael Wagner, Bernd Henkel, Siegfried Stengelin, Andreas Evers, Martin Bossart |
2020-09-01 |
$13,326,000 |
| 10538567 |
Compounds as peptidic trigonal GLP1/glucagon/GIP receptor agonists |
Martin Bossart, Andreas Evers, Dieter Kadereit, Katrin Lorenz, Michael Wagner +2 more |
2020-01-21 |
$21,956,000 |
| 10519211 |
Compounds as peptidic GLP1/glucagon/GIP receptor agonists |
Martin Bossart, Andreas Evers, Katrin Lorenz, Dieter Kadereit, Michael Wagner +2 more |
2019-12-31 |
$5,348,000 |
| 10253079 |
Functionalized Exendin-4 derivatives |
Michael Wagner, Bernd Henkel, Siegfried Stengelin, Andreas Evers, Martin Lorenz +1 more |
2019-04-09 |
$12,447,000 |
| 9982029 |
Exendin-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonists |
Martin Bossart, Andreas Evers, Katrin Lorenz, Dieter Kadereit, Michael Wagner +1 more |
2018-05-29 |
$11,844,000 |
| 9932381 |
Exendin-4 derivatives as selective glucagon receptor agonists |
Siegfried Stengelin, Andreas Evers, Michael Wagner, Bernd Henkel |
2018-04-03 |
$18,243,000 |
| 9789165 |
Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonists |
Dieter Kadereit, Katrin Lorenz, Andreas Evers, Michael Wagner, Bernd Henkel +2 more |
2017-10-17 |
$7,245,000 |
| 9775904 |
Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists |
Martin Bossart, Ralf Elvert, Andreas Evers, Siegfried Stengelin, Michael Wagner |
2017-10-03 |
$8,333,000 |
| 9771406 |
Peptidic dual GLP-1/glucagon receptor agonists derived from exendin-4 |
Martin Bossart, Ralf Elvert, Andreas Evers, Siegfried Stengelin, Michael Wagner +1 more |
2017-09-26 |
$18,404,000 |
| 9758561 |
Dual GLP-1/glucagon receptor agonists derived from exendin-4 |
Martin Bossart, Ralf Elvert, Andreas Evers, Siegfried Stengelin, Michael Wagner +1 more |
2017-09-12 |
$14,166,000 |
| 9751926 |
Dual GLP-1/GIP receptor agonists |
Dieter Kadereit, Katrin Lorenz, Andreas Evers, Michael Wagner, Bernd Henkel +2 more |
2017-09-05 |
$7,330,000 |
| 9750788 |
Non-acylated exendin-4 peptide analogues |
Dieter Kadereit, Katrin Lorenz, Andreas Evers, Michael Wagner, Bernd Henkel +2 more |
2017-09-05 |
$7,330,000 |
| 9745360 |
Dual GLP1/GIP or trigonal GLP1/GIP/glucagon agonists |
Michael Wagner, Bernd Henkel, Siegfried Stengelin, Andreas Evers, Martin Lorenz +1 more |
2017-08-29 |
$18,132,000 |
| 9694053 |
Dual GLP-1/glucagon receptor agonists |
Michael Wagner, Bernd Henkel, Siegfried Stengelin, Andreas Evers, Martin Bossart +1 more |
2017-07-04 |
|
| 9670261 |
Functionalized exendin-4 derivatives |
Michael Wagner, Bernd Henkel, Siegfried Stengelin, Andreas Evers, Martin Lorenz +1 more |
2017-06-06 |
$14,464,000 |
| 9365632 |
Exendin-4 derivatives as dual GLP1/glucagon agonists |
Michael Wagner, Bernd Henkel, Siegfried Stengelin, Andreas Evers, Martin Bossart |
2016-06-14 |
$5,305,000 |
| 9181305 |
Exendin-4 peptide analogues |
Andreas Evers, Michael Wagner, Bernd Henkel, Siegfried Stengelin |
2015-11-10 |
$5,418,000 |
| 8901114 |
Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
Thomas Boehme, Christian Engel, Stefan Guessregen, Gerhard Kretzschmar, Kurt Ritter +1 more |
2014-12-02 |
$55,809,000 |
| 8895547 |
Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
Thomas Boehme, Christian Engel, Stefan Guessregen, Kurt Ritter, Georg Tschank |
2014-11-25 |
$63,922,000 |
| 8871758 |
Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
Thomas Boehme, Christian Engel, Stefan Guessregen, Kurt Ritter, Georg Tschank |
2014-10-28 |
$8,174,000 |
| 8853208 |
Amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments |
Lothar Schwink, Siegfried Stengelin, Matthias Gossel, Gerhard Hessler, Petra Lennig |
2014-10-07 |
$10,376,000 |
| 8846666 |
Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
Thomas Boehme, Christian Engel, Stefan Guessregen, Kurt Ritter, Georg Tschank |
2014-09-30 |
$6,701,000 |